Browse > Article
http://dx.doi.org/10.14776/piv.2015.22.3.206

Intravenous Immunoglobulin Nonresponsive Symptomatic Myocarditis during the Acute Stage of Incomplete Kawasaki Disease  

Sohn, Youngsoo (Department of Pediatrics, Kyungpook National University School of Medicine)
Kim, Yeo Hyang (Department of Pediatrics, Kyungpook National University School of Medicine)
Publication Information
Pediatric Infection and Vaccine / v.22, no.3, 2015 , pp. 206-209 More about this Journal
Abstract
We report the case of a 7-year-old boy who showed treatment-nonresponsive hypotension (59/29 mmHg) and decreased left ventricular systolic function (fractional shortening 22%) in the acute stage of Kawasaki disease (KD). The present case serves to highlight that methylprednisolone pulse therapy should be considered in patients with intravenous immunoglobulin nonresponsive symptomatic myocarditis during the acute stage of KD.
Keywords
Kawasaki disease; Corticosteroids; Myocarditis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Falcini F, Capannini S, Rigante D. Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatr Rheumatol Online J 2011;9:17.   DOI
2 Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr 2004;16:508-14.   DOI
3 Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 2014;33:24-7.   DOI
4 Kuwabara M, Yashiro M, Kotani K, Tsuboi S, Ae R, Nakamura Y, et al. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan. J Epidemiol 2015;25:189-93.   DOI
5 Aggarwal P, Suri D, Narula N, Manojkumar R, Singh S. Symptomatic myocarditis in Kawasaki disease. Indian J Pediatr 2012;79:813-4.   DOI
6 Yoshikawa H, Nomura Y, Masuda K, Hazeki D, Yotsumoto K, Arata M, et al. Four cases of Kawasaki syndrome complicated with myocarditis. Circ J 2006;70:202-5.   DOI
7 Schultheiss HP, Kuhl U, Cooper LT. The management of myocarditis. Eur Heart J 2011;32:2616-25.   DOI
8 Rosenfeld EA, Shulman ST, Corydon KE, Mason W, Takahashi M, Kuroda C. Comparative safety and efficacy of two immune globulin products in Kawasaki disease. J Pediatr 1995;26:1000-3.
9 Singh S, Rohit M, Gupta A, Suri D, Rawat A. Late symptomatic myocarditis in Kawasaki disease: an unusual manifestation. Indian J Pediatr 2014;81:404-5.   DOI
10 Saneeymehri S, Baker K, So TY. Overview of pharmacological treatment options for pediatric patients with refractory kawasaki disease. J Pediatr Pharmacol Ther 2015;20:163-77.
11 Fan PC, Chiu CH, Yen MH, Huang YC, Li CC, Lin TY. School-aged children with Kawasaki disease: high incidence of cervical lymphadenopathy and coronary artery involvement. J Paediatr Child Health 2003;39:55-7.   DOI